LIVE Cytotoxicity Assay

Nanolive’s revolutionary LIVE Cytotoxicity Assay leverages AI and high-content live cell data to comprehensively analyze cell viability and phenotypic changes over time. The LIVE Cytotoxicity Assay is the only completely label-free approach to profile living, apoptotic, and necrotic cells, making it a must-have tool in drug development. Thanks to this label-free method, cytotoxic effects can confidently be attributed to the drug under examination, free from the interference of exogenous chemical dyes and labels. Empower early decision making and de-risk lead candidates in preclinical drug development with the LIVE Cytotoxicity Assay’s reliable toxicity assessments. ​

The LIVE Cytotoxicity assay also offers fluorescence analysis as an optional yet integrated feature. Fluorescence monitoring allows for measurement of fluorescent reporter genes or drug delivery particles in cells, as well as the differentiation of cellular sub-populations in co-cultures. Coupled with the AI-based analysis of cellular viability, the LIVE Cytotoxicity Assay allows researchers to determine if uptake of drugs is associated with an effect on cell health, or to measure the specificity of their drug in co-cultures. This capability accelerates drug development by streamlining workflows and unlocking deep cellular insights, allowing for the prioritization of the most promising lead candidates, and optimizing drug development timelines.